For sales

Highlights from the Week of 31st August – 07th September in the world of pharma and healthcare!

Highlights from the week of 31st Aug - 07th Sep PharmaEssentia ( FDA, Approval ) FDA approves PharmaEssentia's BESREMi to treat adults with Essential Thrombocythemia, regardless of genotype or disease status Ionis ( FDA, Approval ) Ionis' ZANVASTRO gets FDA approval to treat Alexander disease in pediatric and adults patients AstraZeneca ( FDA, Approval ) FDA provides approval to AstraZeneca's ETCAMAH, in combination with CDK 4/6 inhibitor, to treat adults with HR-positive, HER2- negative, locally advanced or metastatic breast cancer AstraZeneca ( EU, Approval ) AstraZeneca's ENHERTU, in combination with pertuzumab, gets EU approval to treat adults with unresectable or metastatic HER2-positive breast cancer All logos and trademarks remain the intellectual properties of their respective owners
Download

Connect with us

Please fill in the information below, and we'll get back to you.